A detailed history of State Of Wisconsin Investment Board transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 28,550 shares of LGND stock, worth $3.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
28,550
Previous 34,732 17.8%
Holding current value
$3.19 Million
Previous $2.93 Million 2.29%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$82.7 - $110.11 $511,251 - $680,700
-6,182 Reduced 17.8%
28,550 $2.86 Million
Q2 2024

Aug 14, 2024

SELL
$68.53 - $87.91 $155,083 - $198,940
-2,263 Reduced 6.12%
34,732 $2.93 Million
Q1 2024

May 14, 2024

BUY
$68.64 - $89.2 $1.63 Million - $2.12 Million
23,805 Added 180.48%
36,995 $2.7 Million
Q4 2023

Feb 12, 2024

SELL
$49.57 - $72.63 $5,452 - $7,989
-110 Reduced 0.83%
13,190 $942,000
Q3 2023

Nov 14, 2023

SELL
$58.86 - $72.67 $35,551 - $43,892
-604 Reduced 4.34%
13,300 $796,000
Q2 2023

Aug 14, 2023

SELL
$69.53 - $79.33 $58,891 - $67,192
-847 Reduced 5.74%
13,904 $1 Million
Q1 2023

May 15, 2023

SELL
$65.67 - $77.08 $108,618 - $127,490
-1,654 Reduced 10.08%
14,751 $1.09 Million
Q4 2022

Feb 14, 2023

SELL
$61.72 - $96.74 $33,020 - $51,755
-535 Reduced 3.16%
16,405 $1.1 Million
Q3 2022

Nov 14, 2022

SELL
$0.01 - $107.56 $11 - $121,650
-1,131 Reduced 6.26%
16,940 $1.46 Million
Q2 2022

Aug 15, 2022

SELL
$74.52 - $117.06 $99,037 - $155,572
-1,329 Reduced 6.85%
18,071 $1.61 Million
Q1 2022

May 13, 2022

SELL
$94.99 - $151.56 $208,978 - $333,432
-2,200 Reduced 10.19%
19,400 $2.18 Million
Q4 2021

Feb 11, 2022

BUY
$127.69 - $165.85 $280,918 - $364,870
2,200 Added 11.34%
21,600 $3.34 Million
Q1 2021

May 17, 2021

SELL
$99.52 - $215.83 $109,472 - $237,413
-1,100 Reduced 5.37%
19,400 $2.96 Million
Q4 2020

Feb 03, 2021

SELL
$80.55 - $106.05 $209,430 - $275,730
-2,600 Reduced 11.26%
20,500 $2.04 Million
Q2 2020

Aug 12, 2020

SELL
$68.28 - $123.65 $225,324 - $408,045
-3,300 Reduced 12.5%
23,100 $2.58 Million
Q1 2020

May 06, 2020

SELL
$63.37 - $107.88 $253,480 - $431,520
-4,000 Reduced 13.16%
26,400 $1.92 Million
Q2 2019

Aug 14, 2019

BUY
$107.38 - $129.34 $204,022 - $245,746
1,900 Added 6.67%
30,400 $3.47 Million
Q1 2019

May 13, 2019

BUY
$105.93 - $142.47 $730,917 - $983,043
6,900 Added 31.94%
28,500 $3.58 Million
Q4 2018

Feb 11, 2019

BUY
$128.36 - $272.13 $38,508 - $81,639
300 Added 1.41%
21,600 $2.93 Million
Q2 2018

Aug 03, 2018

BUY
$150.77 - $207.98 $150,770 - $207,980
1,000 Added 4.93%
21,300 $4.41 Million
Q4 2017

Feb 08, 2018

BUY
$128.36 - $147.04 $680,308 - $779,312
5,300 Added 35.33%
20,300 $2.78 Million
Q3 2017

Nov 01, 2017

BUY
$120.91 - $137.94 $1.81 Million - $2.07 Million
15,000
15,000 $2.04 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.88B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.